Warning: The NCBI web site requires JavaScript to function. more...
Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.
Javle M, Hsueh CT.
J Hematol Oncol. 2009 Feb 23;2:9.
Related citations
Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology.
J Hematol Oncol. 2010 Mar 23;3:11. Review.
Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.
Saif MW.
JOP. 2007 Jul 9;8(4):365-73.
Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Brus C, Saif MW.
JOP. 2010 Jul 5;11(4):321-3. Review.
Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Li J, Merl MY, Chabot J, Saif MW.
JOP. 2010 Jul 5;11(4):310-2. Review.
First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merl MY, Abdelghany O, Li J, Saif MW.
JOP. 2010 Jul 5;11(4):317-20. Review.
A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.
Acta Oncol. 2001;40(2-3):282-308. Review.
Updates in pancreatic neuroendocrine carcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Alsamarai S, Libutti SK, Saif MW.
JOP. 2010 Jul 5;11(4):336-40. Review.
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
Shih T, Lindley C.
Clin Ther. 2006 Nov;28(11):1779-802. Review.
Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.
Hurwitz H.
Clin Colorectal Cancer. 2004 Oct;4 Suppl 2:S62-8. Review.
Clinical overview: adjuvant therapy of gastrointestinal cancer.
Macdonald JS.
Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S4-11. Review.
Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.
Tappenden P, Jones R, Paisley S, Carroll C.
Health Technol Assess. 2007 Mar;11(12):1-128, iii-iv. Review.
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
JOP. 2008 Mar 8;9(2):91-8.
Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006.
JOP. 2006 Jul 10;7(4):337-48.
Integration of novel agents in the treatment of colorectal cancer.
Iqbal S, Lenz HJ.
Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S32-9. Review.
Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Chang BW, Siccion E, Saif MW.
JOP. 2010 Jul 5;11(4):313-6. Review.
[ASCO-Update 2005--Highlights of the 41st Meeting of the American Society of Clinical Oncology/ASCO 2005].
Höhler T, Heike M, Lutz MP, Graeven U, Seufferlein T; American Society of Clinical Oncology.
Z Gastroenterol. 2005 Nov;43(11):1253-9. German.
Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.
Adv Exp Med Biol. 2007;608:1-22. Review.
Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
Li J, Saif MW.
JOP. 2009 Jul 6;10(4):361-5.
[Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
Medinger M, Steinbild S, Mross K.
Praxis (Bern 1994). 2004 Sep 29;93(40):1633-44. Review. German.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on